Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Serotonin norepinephrine

FIGURE 30-2. Pain algorithm. AED, antiepileptic drug APAP, acetaminophen NSAID, non-steroidal antiinflammatory drug SNRI, serotonin-norepinephrine reuptake inhibitor SSRI, selective serotonin reuptake inhibitor TCA, tricyclic antidepressant. [Pg.493]

Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), alleviates anxiety in GAD patients with and without... [Pg.611]

BiPAP bi-level positive airway pressure SNRI serotonin norepinephrine reuptake inhibitor SSRI selective serotonin reuptake inhibitor... [Pg.631]

Sibutramine and its two active metabolites (Mj and M2) exert their effect by inhibiting the reuptake of serotonin, norepinephrine, and dopamine.29 Appetite becomes suppressed because patients feel a sense of satiety. [Pg.1533]

After neurotransmitter molecules have influenced the firing of a receiving neuron (more technically called a postsynaptic neuron), some of them are destroyed by enzymes in the synaptic cleft (the synapse), some are reabsorbed by the sending presynaptic neuron in a process that is called reuptake , and the rest remain in the space between the two neurons. The chemical-imbalance hypothesis is that there is not enough serotonin, norepinephrine and/or dopamine in the synapses of the brain. This is more specifically termed the monoamine theory of depression, because both serotonin and norepinephrine belong to the class of neurotransmitters called monoamines. [Pg.82]

There are a few substances that can reduce serotonin, norepinephrine and/or dopamine rapidly and substantially, reducing them to levels thought to be lower than those of depressed patients.23 That is what reserpine was supposed to do and, as we have seen, it did not cause depression - despite the early clinical impression that it did. Other substances have been used in later studies, the most common of which are amino-acid mixtures that lack the essential amino acids needed by the body to produce these neurotransmitters. For example, having people drink a beverage that is rich in amino acids, but does not contain tryptophan (the amino acid needed to produce serotonin), lowers their serotonin levels within a couple of hours. [Pg.91]

FDA, Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans), Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) May Result in Life-Threatening Serotonin Syndrome , FDA Public Health Advisory (2006) http //www.fda.gov/Cder/Drug/advisory/ S SRI S S200607.htm... [Pg.201]

MAOI (Monoamine Oxidase Inhibitors) will intensify and prolong the effects of NN-DMT, however this is never recommended. Foolish combinations of MAOIs and other drugs can lead to serious health problems and even death. The tryptamines are normally metabolized by an MAO in the body. MAO metabolizes serotonin, norepinephrine, and dopamine. By inhibiting this, MAOIs increase levels of those neurotransmitters. Tyramine will not be metabolized and will cause an increase in tyramine levels in blood. [Pg.5]

Patients sustain convulsions and neurological deterioration. The urine contains low levels of the metabolites of serotonin, norepinephrine and dopamine. The reductase also plays a role in the maintenance of tetrahydrofolate levels in brain, and some patients have had low folate levels in the serum and CNS. Treatment has been attempted with tryptophan and carbidopa to improve serotonin homeostasis and with folinic acid to replete diminished stores of reduced folic acid. This therapy is sometimes effective. Diagnosis involves assay of DHPR in skin fibroblasts or amniotic cells. Phenylalanine hydroxylase activity is normal. [Pg.673]

The CNS also contains a descending system for control of pain transmission. This system originates in the brain and can inhibit synaptic pain transmission at the dorsal horn. Important neurotransmitters here include endogenous opioids, serotonin, norepinephrine, y-aminobutyric acid, and neurotensin. [Pg.627]

CBT and social skills training are effective in children with SAD. Evidence supports the efficacy of SSRIs and serotonin norepinephrine reuptake inhibitors in children 6 to 17 years of age. Individuals up to 24 years of age should be closely monitored for increased risk of suicidality. [Pg.763]

The serotonin-norepinephrine reuptake inhibitors include venlafaxine and duloxetine. Venlafaxine is an inhibitor of 5-HT and NE reuptake and a weak inhibitor of DA reuptake. Desvenlafaxine (Pristiq) was recently approved by the FDA. The dose is 50 mg once daily. [Pg.798]

There are three approved drugs, venlafaxine (16), duloxetine (17) and milnacipran (18), in the serotonin-norepinephrine reuptake inhibitor (SNRI) class. Whereas milnacipran blocks 5-HT and NE reuptake with almost equal potency, venlafaxine and duloxetine block 5-HT reuptake preferentially [39-41]. Clinical evidence shows that SNRIs have comparable efficacy in the treatment of MDD compared with antidepressants in the SSRI class. An advantage with SNRIs appears to be the ability of alleviating chronic pain associated with, and independent of depression [42-44],... [Pg.18]

FIGURE 4.32 Structures of the MAO-A substrates (serotonin, norepinephrine), their deaminated metabolites, and its selective inhibitor, clorgyline, as well as the structures of the MAO-B substrates (/3-phenethylamine, trytamine), their deaminated metabolites, and its selective inhibitors, deprenyl and pargyline. [Pg.63]

Hwang EC, Van Woert MH. 1979. Serotonin-norepinephrine interactions in the tremorolytic actions of phenoxybenzamine and trazodone. Pharmacol Biochem Behav 10(1) 27-29. [Pg.262]

Another problem in validating targets for behavioral disorders related to neurotransmitter abnormalities is the interplay between several neurotransmitter systems in specific brain regions. For example, in the hippocampus, limbic, and nigral-striatal areas, functions connected by serotonin, norepinephrine, and dopamine are interconnected so that blocking selected receptor subtypes or changing synaptic levels of certain neurotransmitters may... [Pg.228]

SSRI = selective serotonin reuptake inhibitor SNRI = serotonin norepinephrine reuptake inhibitor ARB = angiotensin receptor blocker ACE = angiotensin converting enzyme COX-2 = cyclooxygenase 2 ADHD = attention deficit hyperactivity disorder. [Pg.22]

Venlafaxine (Effexor, Wyeth) Central nervous system Serotonin-norepinephrine reuptake inhibitor... [Pg.40]


See other pages where Serotonin norepinephrine is mentioned: [Pg.211]    [Pg.260]    [Pg.65]    [Pg.489]    [Pg.498]    [Pg.500]    [Pg.591]    [Pg.619]    [Pg.628]    [Pg.803]    [Pg.812]    [Pg.91]    [Pg.92]    [Pg.213]    [Pg.190]    [Pg.385]    [Pg.478]    [Pg.620]    [Pg.760]    [Pg.764]    [Pg.795]    [Pg.796]    [Pg.799]    [Pg.802]    [Pg.806]    [Pg.150]    [Pg.264]    [Pg.300]   


SEARCH



Antidepressants serotonin-norepinephrine reuptake inhibitors

Catecholamines dopamine norepinephrine serotonin

Dual serotonin-norepinephrine reuptake

Dual serotonin-norepinephrine reuptake inhibitors

Monoamines norepinephrine serotonin

Neurotransmitters Include Norepinephrine, Acetylcholine, Dopamine, Serotonin, and GABA

Neurotransmitters norepinephrine serotonin

Norepinephrine

Norepinephrine reuptake with serotonin inhibition

Reuptake Dual Selective Serotonin Norepinephrine

SNRI (serotonin norepinephrine reuptake

SNRIs (serotonin-norepinephrine reuptake

SSNRI (selective serotonin norepinephrine

SSNRI (selective serotonin norepinephrine Reuptake

Selective Serotonin-Norepinephrine Reuptake Inhibitors

Selective serotonin and norepinephrine

Selective serotonin and norepinephrine reuptake inhibitors

Serotonin and norepinephrine

Serotonin and norepinephrine reuptake inhibitors

Serotonin and norepinephrine reuptake inhibitors SNRIs)

Serotonin norepinephrine reuptake inhibitors

Serotonin with norepinephrine release, alpha

Serotonin-norepinephrine agents

Serotonin-norepinephrine drug interactions

Serotonin-norepinephrine reuptake

Serotonin-norepinephrine reuptake dosage

Serotonin-norepinephrine reuptake inhibitor SNRI)

Serotonin-norepinephrine reuptake inhibitor drug

Serotonin-norepinephrine reuptake inhibitors SNRIs)

Serotonin-norepinephrine reuptake pharmacokinetics

Serotonin-norepinephrine reuptake relative potency

Serotonin-norepinephrine reuptake side effects

Serotonin-norepinephrine specific agents

© 2024 chempedia.info